A bumpy ride on the diagnostic bench of massive parallel sequencing, the case of the mitochondrial genome

PLoS One. 2014 Nov 10;9(11):e112950. doi: 10.1371/journal.pone.0112950. eCollection 2014.

Abstract

The advent of massive parallel sequencing (MPS) has revolutionized the field of human molecular genetics, including the diagnostic study of mitochondrial (mt) DNA dysfunction. The analysis of the complete mitochondrial genome using MPS platforms is now common and will soon outrun conventional sequencing. However, the development of a robust and reliable protocol is rather challenging. A previous pilot study for the re-sequencing of human mtDNA revealed an uneven coverage, affecting predominantly part of the plus strand. In an attempt to address this problem, we undertook a comparative study of standard and modified protocols for the Ion Torrent PGM system. We could not improve strand representation by altering the recommended shearing methodology of the standard workflow or omitting the DNA polymerase amplification step from the library construction process. However, we were able to associate coverage bias of the plus strand with a specific sequence motif. Additionally, we compared coverage and variant calling across technologies. The same samples were also sequenced on a MiSeq device which showed that coverage and heteroplasmic variant calling were much improved.

Publication types

  • Consensus Development Conference
  • Research Support, Non-U.S. Gov't

MeSH terms

  • DNA, Mitochondrial / genetics
  • Gene Library
  • Genome, Mitochondrial*
  • High-Throughput Nucleotide Sequencing / methods*
  • Humans
  • Molecular Diagnostic Techniques / methods*
  • Pilot Projects
  • Sensitivity and Specificity
  • Sequence Analysis, DNA / methods*

Substances

  • DNA, Mitochondrial

Grants and funding

This work was supported by Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO; www.FWO.be) G.0.200; The ‘Association Belge contre les Maladies Neuro-Musculaires (ABMM)’ (http://www.hospichild.be/fr/associations/maladies-neuro-musculaires/association-belge-contre-les-maladies-neuro-musculaires-asbl-abmm-maladies-genetiques), and Vrije Universiteit Brussel (with reference OZR1928 and OZRMETH3). Authors who received funding: CS LDM SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.